A case report of acute fibrinous and organizing pneumonia

Kaige Wang1, Xinmiao Du1, Qian Wu2

  • 1Department of Respiratory and Critical Care Medicine.

Medicine
|December 6, 2019
PubMed
Abstract

Insights

Acute fibrinous and organizing pneumonia (AFOP) is a rare lung disease. Early diagnosis via lung biopsy and effective treatment with corticosteroids offer an excellent prognosis for patients with AFOP.

Area of Science:

  • Pulmonology
  • Pathology

Background:

  • Acute fibrinous and organizing pneumonia (AFOP) is a rare, non-infectious lung disease.
  • Histological hallmarks include intra-alveolar fibrin balls, complicating diagnosis.
  • Often misdiagnosed as common lung infections.

Observation:

  • A male patient presented with high-grade fever and chills for 15 days, initially treated as a lung infection.
  • The patient showed no response to antibiotic therapy.
  • Diagnosis was confirmed through lung biopsy and histopathology.

Findings:

  • AFOP is characterized by bilateral basilar infiltrates and specific histological findings.
  • Lung biopsy and histopathology are crucial for accurate AFOP diagnosis.
  • Methylprednisolone (a glucocorticoid) at 40mg daily resulted in a positive patient response.

Implications:

  • Glucocorticoids are effective treatments for AFOP.
  • Prompt diagnosis and corticosteroid treatment lead to an excellent prognosis for subacute AFOP cases.
  • Increased awareness of AFOP can improve patient outcomes by preventing misdiagnosis and delayed treatment.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
736
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
667
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
398
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
243
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
702